Creative Biolabs Reinforces Rheumatic Disease Research by Comprehensive Autoantibody Service

June 16 22:11 2022
Creative Biolabs introduces comprehensive NAA services and products covering a wide range of potential markers for rheumatic disease research.

New York, USA – June 16, 2022 – The advent of biologic therapies, particularly antibody therapeutics, has revolutionized the pharmacological treatment of many rheumatic diseases. As the natural autoantibodies (NAAs) show strong associations with rheumatic disease manifestations, prognosis and treatment responses, they have been incorporated into disease classification criteria, and are convenient biomarkers for assisting in the diagnosis of many autoimmune rheumatic disorders.

Fully understanding the impact scientific discovery and development have on society and how it affects people and human health, the expert team at Creative Biolabs has been committed to offering comprehensive NAA services and detection kits, especially for rheumatic disease research projects.

One-stop NAA Services for Rheumatic Disease Research

With years of experience and advanced technologies, Creative Biolabs can provide one-stop NAA services, from NAA detection, NAA profiling, affinity measurement to NAA epitope or paratope mapping. High batch-to-batch consistency is ensured on every project of custom experimental design.

In particular, the team has gained much experience in NAA detection service. As NAAs play critical roles in rheumatic disease, during the early diagnosis and treatment of these diseases, the detection and analysis of them exhibit great importance. Creative Biolabs provides several conventional methods to detect NAA, including western blot, enzyme-linked immunosorbent assay (ELISA), immunofluorescent staining, immunosensors, antigen arrays, and so on.

Markers for NAA-associated Rheumatic Diseases

Powered by a series of innovative and diversified NAA platforms, the professional team provides services covering a full range of markers for disease diagnosis and therapeutic monitoring. The most potential marks include anti-rheumatoid factor (RF), anti-neutrophil cytoplasmic antibody (ANCA), anti-nuclear antibody (ANA), anti-cyclic citrullinated peptide (ACPA), anti-dsDNA, anti-citrullinated cyclic peptide (CCP), etc.

NAA Products for Rheumatic Disease Research

A wide spectrum of NAA detection kits is also pre-made for studying disease pathways, screening for potential drug candidates, and evaluating biopharmaceutical production processes. Featured products for rheumatic disease research include:

* Human dsDNA Autoantibody (IgG) ELISA kit

* Human Anti-citrullinated protein antibodies (ACPAs) ELISA kit

* Human ANCA-C PR3 Autoantibody (IgG) ELISA kit

At Creative Biolabs, the focus is always on enabling access to quality products and services, thus ushering clients’ projects from early discovery all the way to the clinic. Check the official website to learn more about the NAA-related services and products: https://www.creative-biolabs.com/natural-autoantibody.

About Creative Biolabs

With an unrelenting drive in bio-science research and industry, Creative Biolabs has successfully developed a new range of natural autoantibody (NAA) platforms to provide fast and convenient NAA services, covering NAA detection, profiling, affinity measurement, and NAA epitope/paratope mapping. In addition, a portfolio of premade or custom NAA products (such as NAA detection assay kits) is also available.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/natural-autoantibody